Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-03-10

Clinical Trial Update: Calcium, Vitamin D and Metformin to Treat Insulin Resistance in Obese African American Adolescent Females [NA]

View source ↗

Summary

The clinical trial evaluating calcium, vitamin D, and metformin for insulin resistance in obese African American adolescent females has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Calcium (Calcium)
  • Vitamin D (Cholecalciferol)
  • metformin (metformin)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Insulin Resistance, Insulin Sensitivity | NA | Status: WITHDRAWN